retatrutide trial results news today Retatrutide, a new weight loss drug not available on the market yet, is showing promising in trials. Dr. LaPook explains it’s doing much more than what current medications can Triple hormone receptor agonist retatrutide

Doses as high as 4,500 mg have been used in scientific studies, but participants took these amounts under controlled, safe conditions for a strictly defined period of time

BPC-157 protects and prevents gastric ulcers

Solutions Focus on calorie-dense protein sources: fatty fish, whole eggs, higher fat dairy, protein powder Use liquid calories strategically: protein shakes, smoothies, milk digest more easily than solid food Time higher calorie meals for windows when appetite is strongest (often morning for many users) Consider dose reduction if appetite suppression is preventing adequate nutrition Set phone reminders to eat every 3 hours regardless of hunger signals Challenge: Energy Fluctuations Affecting Training Some users experience periods of reduced energy, particularly during early adaptation or immediately following dose increases

That's a case for complementary science, not an either-or decision

Hold the syringe with the needle pointing up, and pull down on the plunger until it draws in the same amount of air as the dose of medication youre taking